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ABSTRACT 
Personality disorders (PDs) are associated with many negative health outcomes, 
including overutilization of health care resources, increased risk for chronic health 
problems, and poor adherence to medical recommendations. It is unclear, however, how 
significantly personality pathology affects an individual’s daily health and functioning 
when health problems have already occurred. The purpose of this dissertation was to 
determine whether the presence of PD features moderate individual change over time in 
physical, emotional, and social functioning among individuals with significant health 
problems. The sample included 1,630 community-dwelling participants, ages 55-64. PD 
features were measured at baseline; health problems and all outcome variables were 
measured at baseline and four follow-up assessments. Multilevel modeling analyses were 
used to test the interactions between number of health problems, time, and personality 
disorder features in predicting physical, psychological, and social functioning. The results 
showed that PD features had a significant effect on functioning above and beyond the 
effects of health problems alone. Borderline, avoidant, and dependent PD features, in 
particular, showed significant main effects for all three functional outcome domains. 
Interaction effects with personality pathology were significant for medication use, 
medical resource utilization, and depressed mood. Individuals with borderline pathology 
showed significantly more medication use over the 2.5 years when health problems were 
not present. Individuals with avoidant features used more medical resources over time 
when health problems were present. Furthermore, individuals with antisocial or histrionic 
PD features and a higher number of health problems showed increased depressive mood 
scores over time.  
                                                                    1                                                                 
CHAPTER 1: INTRODUCTION 
There is growing evidence to support the assertion that personality plays an 
important role in general health (Kern & Friedman, 2008; Smith & Mackenzie, 2006). 
Personality disorders (PDs), in particular, are associated with a number of negative health 
outcomes, such as increased risk for chronic health problems and overutilization of 
healthcare services (Bender et al., 2001; Piertzak, Wagner, & Petry, 2007).  It is unclear, 
however, how significantly personality pathology affects individuals’ ability to cope with 
new health problems and the factors that may come from those new health problems, 
such as pain or role limitations.  
As individuals age, physical health problems and illness emerge as common 
stressors. Gaining insight into how individuals experience physical illness or disability is 
important to our understanding of successful aging. Equally important is determining 
whether certain risk factors, like personality pathology, can be identified as indicators for 
maladjustment to major health stressors that are likely to occur.  
PDs, as defined by the Diagnostic and Statistical Manual of Mental Disorders 
(DSM-IV-TR), reflect problematic patterns of perception and behavior that have a 
detrimental effect on individuals’ functioning (APA, 2000). These patterns are thought to 
be inflexible and pervasive across many domains, including cognition, emotional 
responses, interpersonal functioning, and impulse control. The ten specific PDs are 
paranoid, schizoid, schizotypal, antisocial, borderline, histrionic, narcissistic, avoidant, 
dependent and obsessive-compulsive PD. Each PD has its own unique set of defining 
features and with that, its own unique set of problems. In the present paper, we will focus 
 2 
on what functional problems may emerge from PD features in the face of health 
problems. 
Personality Pathology and Physical Health Outcomes 
Longitudinal research on PDs in adolescence (Cohen et al., 2005) and young 
adulthood (Skodol, Gunderson, et al., 2005; Zanarini et al., 2005) has demonstrated that 
personality pathology can lead to detrimental outcomes related to physical health, 
psychological well-being, and general functioning. PDs are associated with a number of 
detrimental physical health outcomes, including increased risk for chronic medical 
conditions (e.g., coronary heart disease) (Pietrzak et al., 2007) and increased likelihood of 
engaging in unhealthy behaviors (e.g., smoking) (Zanarini, Frankenburg, Hennen, Reich, 
& Silk, 2005). PDs also have been shown to have a negative prognostic impact on 
depression, another risk factor for problems with physical health (DiMatteo, Lepper, & 
Croghan, 2000; Skodol, Gunderson et al., 2005).   
The Collaborative Longitudinal Personality Disorders Study (CLPS), a study of 
treatment-seeking individuals ages 18 to 45 (Skodol, Gunderson, et al., 2005), provides 
us with some clear evidence of how PDs impact individuals’ health over time. Generally 
speaking, PDs are associated with increased utilization of medical resources (Bender et 
al., 2001). The investigators found that patients with borderline PD were significantly 
more likely to utilize all types of psychosocial treatments available and were found to use 
antianxiety, antidepression, and antipsychotic drugs at high rates. Obsessive compulsive 
PD was related to more individual psychotherapy and schizotypal PD to more use of 
psychiatric medication, when compared with patients with MDD alone. One limitation of 
the CLPS project is that only four PDs were selected for inclusion during this study (i.e., 
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schizotypal, borderline, avoidant, and obsessive-compulsive), making it difficult to draw 
conclusions about association across the full range of personality pathology with physical 
health problems. 
Other studies have supported the specific health risk associated with borderline 
PD. A longitudinal study of borderline PD patients by Zanarini et al. (2005) confirmed 
the increased rates of medical use among individuals with borderline PD and also showed 
that unremitted borderline PD patients had more difficulty with chronic medical 
conditions. Even among borderline PD patients who are older (i.e., early to mid forties) 
and show fewer symptoms, the risk for overuse of medical services and worse 
functioning is still present (Blum et al., 2008). Furthermore, using data from the Wave 2 
National Epidemiological Survey on Alcohol and Related Conditions (NESARC), El-
Gabalawy et al. (2010) found that borderline PD was associated with a greater likelihood 
of having hypertension, hepatic disease, cardiovascular disease, gastrointestinal disease, 
arthritis, venereal disease or “any assessed medical condition,” even when controlling for 
other psychopathology and sociodemographic variables relevant to physical health.  
Findings from a longitudinal study of adult inpatients with borderline PD (Frankenburg & 
Zanarini, 2006a) also showed that borderline PD is associated with obesity. 
Despite growing evidence of health risks associated with personality pathology, 
the majority of research up to now has been done with clinical samples of younger adults 
(Oltmanns & Balsis, 2011). Two reports from the St. Louis Personality and Aging 
Network project (SPAN) provide preliminary evidence of the negative effects of 
personality pathology on health outcomes in a middle- to older-aged adult community 
sample. First, using cross-sectional data, Powers and Oltmanns (in press, A) examined 
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whether PD features were associated with subjective perception of health. Subjective 
perception of health is widely recognized in current research as an important indicator of 
future health outcomes, including mortality, health behaviors, and healthcare utilization 
(Fayers & Spranger, 2002). The results demonstrated that personality pathology 
explained a significant amount of variance in negative health perceptions independent of 
objective health indicators and general personality characteristics. Furthermore, Powers 
and Oltmanns (in press, B) found that PD features were predictive of worse physical 
functioning scores, greater healthcare utilization, and greater medication use at 6 month 
follow-up, even when baseline levels of functioning, the presence of illness, and 
depression were controlled. In both studies, borderline pathology was related to worse 
perceived health and functioning above and beyond other PD features. These preliminary 
studies demonstrate the relevance of personality pathology to many aspects of health in 
later adulthood, including both subjective feelings about health and objective aspects of 
health relevant to daily life, such as medication use, pain, and energy level. 
The Importance of Personality Pathology in the Experience of Health Problems  
Stressful life events often precipitate negative psychological outcomes, such as 
the onset of a major depressive episode (Monroe & Harkness, 2005; Wu & Andersen, 
2010).  The kinds of stressors that affect individuals change over the lifespan, with 
interpersonal stressors being more common in young adulthood and physical health 
problems more common in middle age and older adulthood (Jordanava et al., 2007). 
Personality pathology is associated with decreased psychosocial functioning following 
stressful experiences in younger people (Pagano et al., 2004), and it is possible that this 
may also translate into health-specific difficulties in later adulthood.   
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PDs influence the way that individuals perceive their health and physical 
functioning (Chen et al., 2009; Powers & Oltmanns, in press, A; Skodol, Grilo et al., 
2005), which can in turn affect how an individual deals with the experience of health 
problems (Roberts, 2009). We know that variability in physical functioning and disability 
is affected by psychological factors (e.g., personality) (Turk & Okifuji, 2002). 
Furthermore, an individual’s perception of a chronic physical illness (e.g., chronic pain) 
predicts functional outcomes, including adherence to medical treatment or time away 
from work following a surgery (Groarke et al., 2004; Petrie et al., 1996; Scharloo et al., 
1998). The presence of multimorbidity must also be kept in mind because it can have a 
large effect on the experience of illness (Fortin et al., 2006). Dealing with the stress of 
one chronic physical condition may be very different than dealing with the stress of three 
conditions, and so the role of PD features in relation to health problems may change as 
illness load increases.  
Social functioning also plays an important role in health maintenance and a strong 
social support network can help protect against the onset and progression of chronic 
conditions such as cardiovascular disease, cancer, and infectious disease (Cohen, 1988; 
Uchino, 2009). Family or friend support makes it easier for individuals to cope with daily 
stress and manage the course of chronic conditions. Interestingly, researchers suggest that 
perceived social support may be more important than actual received support in 
predicting health outcomes, and personality can affect those perceptions (Uchino, 2009). 
With this in mind, levels of social functioning or adjustment may be particularly 
important to consider in relation to personality pathology because one of the central 
characteristics of PDs is dysfunction in interpersonal relationships. The disorders that 
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cause individuals to avoid social contact, such as avoidant PD and schizoid PD, may be 
especially relevant to this aspect of health and functioning. Other PDs that are related to 
chaotic interpersonal relationships and tend to drive people away, such as borderline or 
narcissistic PD, may also be relevant here. 
The Present Study and Specific Aims 
 As individuals age, the risk of developing a major medical condition increases, 
and the stress that accompanies major health problems can make it difficult to function 
and manage daily tasks. There is a great deal of variability in how individuals handle 
health problems, and personality pathology may play a key role in understanding these 
individual differences. Many of the studies reviewed here have emphasized the 
detrimental role of personality pathology in specific negative physical health outcomes, 
with borderline pathology emerging as particularly important. Despite extensive research 
into the influence of personality on mental and physical health outcomes (see Kern & 
Friedman, 2008; Lahey, 2009 for reviews), however, there is a scarcity of information on 
how pathological personality patterns affect the dynamic relationship between personality 
and general functioning when health problems arise. Furthermore, the inadequate 
research available on PDs in later adulthood makes it difficult to understand fully the role 
of personality pathology on health across the lifespan (Oltmanns & Balsis, 2011). 
Identifying the relationship between PD features and general functioning in the presence 
of major medical conditions (e.g., rheumatoid arthritis, heart disease) will broaden our 
understanding of how personality affects our health.  
The present study assessed whether personality pathology impacted physical, 
psychological, and social functioning in the presence of physical health problems among 
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a community sample of middle- to older-aged adults. More specifically, patterns of 
change in physical functioning (i.e., healthcare and medication use, physical functioning, 
and perceived health), psychological functioning (i.e., depressed mood and emotional 
well-being), and social functioning (i.e., perceived relationship quality with family and 
friends) were examined in relation to the presence of major health problems over 2.5 
years. Then, we tested whether the presence of PD features moderated those patterns of 
individual change. We predicted that increased numbers of symptoms of borderline PD 
would moderate the impact of health problems on medication use and healthcare 
utilization, as well as depressed mood and emotional well-being. Associations with the 
other nine DSM-IV PDs were also explored since less is known about the role of other 
PD symptoms in physical health outcomes and general functioning, especially in later 
adulthood. 
CHAPTER 2: METHODS 
Overview 
 The specific aims outlined above will be tested in the context of a larger 
longitudinal community-based study being conducted by Thomas F. Oltmanns, PhD: the 
St. Louis Personality and Aging Network (SPAN).  Methods and measures relevant to the 
current analyses will be described here. Only the relevant methods used in the study will 
be discussed.  
For the SPAN study, participants were recruited using listed phone numbers that 
were crossed with current census data in order to identify households with one member in 
the targeted age range.  Households were asked to identify all eligible residents between 
the ages of 55 and 64, and the Kish method (Kish, 1949) was used to identify the target 
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participant if more than one person was in that age range. Baseline assessment for 
participants in the SPAN study took approximately three hours and included a brief life 
narrative, a semi-structured diagnostic interview for personality disorders, and several 
self-report measures. After completing the baseline measures, participants were asked to 
complete a brief self-report assessment (30 minutes) once every 6 months. Participants 
received $60 compensation for the baseline assessment and $20 for each 6-month follow-
up (FU) (Oltmanns & Gleason, 2011). Written and verbal informed consent was obtained 
from all participants prior to the baseline assessment.   
Participants 
By April, 2011, we obtained a representative sample (N=1630) of St. Louis 
residents, with ethnic diversity comparable to that of the greater St. Louis metropolitan 
area: 65.0% Caucasian, 32.4% African American, 1.1% Hispanic, 0.4% Biracial, 0.4% 
Middle Eastern, 0.3% Asian, and 0.4% other. The average age of participants was 59.5 
(SD=2.7) and 55% were female. Most participants were married (48%), followed by 
divorced (29%), never married (14%), widowed (7%), and separated (2%). The 
participants varied in educational achievement with 32% having a high school education 
or less, 16% having education beyond high school, but not a bachelor degree, 26% 
having completed a bachelor degree, and 26% having a master degree or more. The 
median household income was $40,000-$60,000 and approximately 65% of participants 
were employed at the time of the baseline assessment.  
On November 1, 2011, all data for FU1 - FU4 that had been collected was also 
obtained, resulting in the following sample sizes: For FU1, n=1442; for FU2, n=1317; for 
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FU3, n=989; for FU4, n=843
1
. These sample sizes reflect all participants who had 
completed the demographics questionnaire and provided information on current health 
status. Completed data for all measures were not obtained from all participants; therefore, 
sample size varies depending on the dependent variables explored. Please see Table 1 for 
a list of sample size by dependent variable for every follow-up
2
. 
Table 1 
Sample sizes for each dependent variable 
Dependent Variable: Baseline FU1 FU2 FU3 FU4 
 N N N N N 
Physical Functioning 
 
1582 1402 1280 981 763 
Health Perception 
 
1583 1416 1304 984 765 
Number of 
Medications 
N/A 1396 1257 948 731 
Medical Resource 
Utilization  
N/A 1313 1207 913 738 
Depression Score 
 
1595 1384 1259 967 757 
Emotional Well-being 
 
1588 1423 1303 990 771 
Social Adjustment 
 
1344 1242 1120 849 678 
 
Procedure 
New health problems were identified in a number of ways. First, baseline levels 
of health problems were determined by a structured interview (see the baseline measures 
section below). Then, the presence of new health problems was assessed at all four 
follow-up assessments, and a count of major physical illnesses or conditions was 
determined at each follow-up. Through a self-report questionnaire, participants were 
                                               
1 The SPAN study is ongoing, so these numbers do not represent attrition from the study, but instead show 
how many people had completed each FU at the time of this project. Current attrition rate for the overall 
SPAN study is 6%. 
2 See statistical plan for an explanation of why missing data is appropriate and manageable given the 
statistical analyses used in the present study. 
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asked to identify whether the onset of a new physical illness, disability, or surgical 
procedure occurred over the previous 6 months and to describe the condition. Inclusion 
criteria for the occurrence of health-related stressors were as follows: (1) for major health 
conditions (e.g., arthritis, diabetes), participants must also report at least one doctor visit 
or (2) for surgery or other medical emergencies (e.g., stroke, knee replacement surgery), 
participants must also report an outpatient procedure or overnight stay in the hospital. 
Health problems were also excluded if there were missing descriptions of the condition, if 
the description only identified a symptom without clearly identifying a physical condition 
(e.g., swelling in ankles), if the condition represented a psychological disorder (e.g., 
bipolar disorder) as opposed to a physical health problem, if a surgery was for cosmetic 
reasons (e.g., eye brow lift), if a routine testing or surgery was described (e.g., 
colonoscopy, mole removal), or if the condition reflected an acute infection (e.g., 
pneumonia, bladder infection)
3
.  
For all physical health conditions that met inclusion criteria, a trained research 
assistant was instructed to code each condition into one of the following categories
4
: 
heart disease, hypertension, high cholesterol, cancer, stroke, diabetes, rheumatic disease, 
chronic lung problem, gastrointestinal disorder, genitourinary problem, osteoporosis, 
chronic pain, brain tumor or aneurism, hernia, broken bone/torn muscle, thyroid problem, 
gastroesophageal reflux disease, eye problem, dental problem, ear problem, joint 
                                               
3 See Appendix 1 for the percentages of physical conditions at each follow-up that were excluded from 
subsequent analyses. 
4
 Questions concerning the nature of the health conditions described by participants were addressed using 
the resources of PubMed Health (http://www.ncbi.nlm.nih.gov/pubmedhealth/s/diseases_and_conditions/). 
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replacement, or other
5
. Table 2 provides the frequency of each condition at all four 
follow-ups
6
. Appendix 1 lists all conditions included in each health condition category.  
Table 2 
Descriptive details of all new reported health problems 
 FU1 FU2 FU3 FU4 
N (%) N (%) N (%) N (%) 
Number of Participants with 
New Health Problems  252 (17.5) 239 (18.1) 174 (17.6) 144 (17.1) 
Type of Condition:     
Heart disease 11 (4.4) 18 (7.6) 15 (8.6) 8 (5.6) 
Hypertension 6 (2.4) 8 (3.3) 6 (3.4) 2 (1.4) 
High Cholesterol 5 (2.0) 5 (2.3) 5 (2.9) 2 (1.4) 
Cancer 22 (8.5) 14 (5.8) 10 (5.7) 7 (4.9) 
Stroke 2 (0.8) 3 (1.3) 3 (1.7) 4 (2.8) 
Diabetes 12 (4.8) 12 (5.1) 11 (6.3) 8 (5.6) 
Rheumatoid Disease 31 (12.3) 27 (11.4) 16 (9.2) 11 (7.6) 
Chronic Lung Problem 7 (2.8) 3 (1.4) 4 (1.5) 3 (2.1) 
Gastrointestinal Disorder 11 (4.4) 10 (4.2) 8 (4.6) 8 (5.6) 
Genitourinary Problem 3 (1.2) 5 (2.1) 6 (3.4) 12 (8.3) 
Osteoporosis 4 (1.5) 2 (1.0) 3 (1.7) 1 (0.7) 
Chronic Pain 59 (23.4) 47 (19.7) 21 (12.1) 30 (20.8) 
Brain Tumor/Aneurism 2 (0.7) 1 (0.5) 1 (0.6) 0 (0.0) 
Hernia 9 (3.6) 10 (4.2) 7 (4.0) 7 (4.9) 
Torn Muscle/Broken Bone 24 (9.5) 19 (8.0) 21 (12.1) 16 (11.1) 
Thyroid Condition 4 (1.5) 6 (2.5) 0 (0.0) 1 (0.7) 
Eye Problem 16 (7.5) 18 (7.6) 12 (6.9) 14 (9.7) 
Dental Problem 4 (1.2) 3 (1.5) 0 (0.0) 1 (0.7) 
Ear Problem 2 (0.5) 2 (0.9) 2 (1.1) 0 (0.0) 
Gastroesophageal reflux disease 3 (1.2) 1 (0.4) 2 (1.1) 0 (0.0) 
Joint Replacement 6 (2.3) 14 (5.8) 14 (8.0) 3 (2.0) 
Other 9 (3.5) 8 (3.4) 7 (4.0) 4 (2.8) 
Note: The percentages for the new health problem reflect percentages of the total 
sample size for each follow-up (FU1, n=1442; FU2, n=1317; FU3, n=989; FU4, 
n=843). All other percentages reflect percentages of all individuals with a new 
health problem. 
 Data obtained over the course of the first 2.5 years of the study (baseline 
interview and four 6-month FU assessments) were used in subsequent analyses. 
                                               
5 The other category included conditions that were extremely rare among participants and did not fit in one 
of the other categories described above (e.g., Parkinson’s disease, traumatic brain injury).  
6 If the participant reported the onset of one or more conditions, the most debilitating was chosen. Coding 
did not affect subsequent analyses; they were used to provide descriptive data on the varied conditions that 
participants faced. 
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Measures 
Baseline Measures 
Structured Interview for DSM-IV Personality (SIDP-IV; Pfohl et al., 1997) is a 
semi-structured interview that elicits information from subjects about the presence or 
absence of all PD criteria in the DSM-IV. Questions are arranged by themes rather than 
by disorders (e.g., work style, interpersonal relationships), and each criterion is rated on a 
scale from 0 (not present) to 3 (strongly present). The SIDP-IV instructs individuals to 
focus on personality traits present in the past five years, thus providing an assessment of 
current personality. PD features (i.e., for paranoid, schizoid, schizotypal, antisocial, 
borderline, histrionic, narcissistic, avoidant, dependent, and obsessive-compulsive PDs) 
were calculated by adding ratings for the relevant criteria for each disorder and taking the 
average. See Table 3 for means and SDs.   
From a clinical perspective, a PD is diagnosed if a certain number of criteria are 
given a minimum rating of 2 on the SIDP. Several participants met full diagnostic criteria 
for at least one specific PD (8.2%), and an additional 14 participants met criteria for PD 
not otherwise specified (PDNOS; 1.8%). However, many more participants met criteria 
for one or more symptoms but did not meet the threshold for a categorical diagnosis. It is 
important to keep in mind that the cut-off points used in DSM-IV-TR for current 
categorical diagnoses are arbitrary and many have shown that this is not the most useful 
way to understand personality pathology (Markon, Krueger, & Watson, 2005, Krueger et 
al., 2011). For example, recent evidence on the structure of borderline personality 
pathology suggests that a diagnostic threshold of 3 symptoms may be more useful 
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(Clifton & Pilkonis, 2007). As described above, we used scaled scores for all subsequent 
analyses. 
All interviews were video-recorded, and 145 interviews were randomly chosen to 
be re-rated by independent judges. Reliability tests indicate adequate reliability at ICC = 
0.67 for the overall scale (all PD's combined) with individual scales ranging from 0.53 
for paranoid to 0.86 for avoidant; borderline had a reliability of 0.77. These numbers are 
consistent with past research on the psychometric properties of the SIDP (Jane et al., 
2006; Pilkonis et al., 1995).  
Table 3 
Descriptive statistics for predictor variables 
 Mean SD Min Max 
Paranoid 0.17 0.26 0.00 1.86 
Schizotypal 0.08 0.15 0.00 2.00 
Schizoid 0.14 0.25 0.00 2.14 
Antisocial 0.05 0.16 0.00 2.14 
Borderline 0.13 0.21 0.00 1.78 
Histrionic 0.14 0.22 0.00 1.75 
Narcissistic 0.18 0.28 0.00 2.33 
Avoidant 0.16 0.34 0.00 2.86 
Dependent 0.08 0.17 0.00 1.63 
Obsessive 
Compulsive 
0.37 0.34 0.00 2.00 
 
Computerized screening version of the Diagnostic Interview Schedule (C-DIS; 
Robins & Helzer, 1994). The DIS is an assessment developed for non-clinicians to collect 
information that could be used to generate psychiatric diagnoses. The DIS has been 
extensively pilot tested, and the validity and reliability of those data indicate good 
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agreement between diagnoses obtained by lay interviewers and clinicians. Health 
problems were assessed using this measure. The health portion of the interview includes 
participants’ report of being under a doctor’s care for the following long-lasting physical 
illnesses: heart disease, cancer, stroke, arthritis, diabetes, hypertension, asthma, hepatitis, 
tuberculosis, bleeding ulcer, and epilepsy.  We calculated the number of chronic 
conditions each participant had at the time of the baseline assessment, regardless of 
original onset date (range 0 – 5, mean = 0.76, SD = 0.93).  
Outcome Measures (obtained at baseline and repeated every 6 months) 
RAND Short Form 36 (SF-36) Health Status Inventory (HSI; Hays & Morales, 
2001) is a self-report questionnaire that provides scores on 8 health constructs including: 
physical functioning, role limitations due to physical/emotional problems, pain, health 
perceptions, emotional well-being, social functioning, and energy.  Extensive data are 
available regarding the reliability and validity of these scales (Moorer et al., 2001). For 
the present analyses, we used the general health perceptions (4 items), emotional well-
being (5 items), and physical functioning composite scores (10 items). All scores were 
computed using the IRT weights determined by Hays and Morales (2001)
7
. Physical 
functioning scores ranged from 209 – 564; general health perception scores ranged from 
46 – 345; emotional well-being scores ranged from 37 – 361. Higher scores indicate 
better functioning. 
Social Adjustment Scale, Self Report (SAS-SR; Weissman & Bothwell, 1976) is a 
48-item instrument that was used as the index of participants’ social adjustment. 
Compared with other interview-based scales, the SAS-SR is more sensitive to change in 
the patient's clinical status and is considered a useful outcome measure in longitudinal 
                                               
7 Full details on the syntax used to compute scores is available upon request. 
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studies. The SAS-SR has been tested in a wide range of populations including community 
samples (Weissman et al., 1978).  For the present study, only the sections on family and 
friend support (17 items, scale 0-2) were used. Questions addressed regularity of social 
contact and size of social network, potential negative social behaviors (e.g., avoidance, 
excessive arguing), and satisfaction with available support. Scores were summed from 
these two categories to create an overall social functioning scale. The total score 
therefore can range from 0-34, with 34 representing better social functioning. 
Beck Depression Inventory II (BDI-II; Beck, Steer, & Brown, 1996) is a 21-item 
self-report measure that has been widely used to measure the severity of depressive 
symptoms in clinical and non-clinical populations. Participants are asked to rate the 
severity of each symptom over the past two weeks, on a scale of 0-3. The total scale score 
therefore ranges from 0-63. Meta-analysis of the internal consistency yields an alpha 
coefficient 0.81 for use with non-psychiatric populations (Beck, Steer, & Carbin, 1988). 
In the present study, BDI total score was used as the measure of depressed mood. 
Demographics Questionnaire. Our supplementary demographics questionnaire 
included questions related to daily health.  Participants were asked to report how often in 
the past 6 months they had: visited a physician’s office, gone to the emergency room, 
stayed overnight in the hospital, had an outpatient procedure, or visited a psychiatrist or 
psychologist (all on a scale of 0, 1-2, 3-5, or 6 or more times).  These were summed to 
create an overall medical resource utilization score. Participants were also asked to 
indicate how many prescription medications they were taking, the dosage for each, what 
the medications were for, and duration of taking the medication. The total number of 
prescription medications was summed for an overall medication use score. 
 16 
Table 4 includes the descriptive statistics for all seven outcome variables across 
all 5 time points.
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Table 4 
Descriptive statistics for dependent variables across all time points 
Dependent  
Variables 
Baseline FU1 FU2 FU3 FU4 
 M SD M SD M SD M SD M SD 
Physical 
Functioning 
477.36 94.01 475.82 94.32 476.99 92.83 476.10 92.82 482.77 88.17 
Health 
Perceptions 
246.98 66.97 248.73 65.99 248.74 65.66 249.81 65.86 252.52 64.66 
Number of 
Medications 
N/A N/A 2.84 2.66 2.91 2.78 2.87 2.66 2.81 2.67 
Medical 
Resource 
Utilization 
N/A N/A 1.64 1.49 1.64 1.42 1.63 1.43 1.69 1.41 
Depression 
Score 
5.24 6.06 5.21 6.42 5.35 6.74 5.38 6.97 4.65 5.95 
Emotional 
Well-being 
265.71 61.86 256.59 64.07 256.74 65.66 255.96 66.34 260.74 63.01 
Social 
Adjustment 
31.01 2.83 30.81 3.30 30.76 3.41 30.94 3.36 31.18 3.12 
Physical functioning, range: 209-564; health perceptions, range: 46-345; number of medications, range: 0-
10; medical resource utilization, range: 0-11; depression score, range: 0-63; emotional well-being, range: 
37-361; social adjustment, range: 14-34. 
                                                                    18                                                                 
Statistical Analyses 
To assess the potential moderating effects of personality on functioning in the 
presence of physical health problems, two-level models were used. Models assessed 
within-person change in physical (i.e., physical functioning, medication use, medical 
resource utilization, and general health perception scores), psychological (i.e., depressed 
mood and emotional well-being scores), and social functioning (i.e., social adjustment 
score) over time and by number of illnesses (level 1), as well as assessed the main and 
moderating effects of personality (level 2). Most multilevel analyses were conducted in 
SPSS using MIXED and unstructured maximum-likelihood (ML) estimates. For 
medication use, we used GENERALIZED ESTIMATING EQUATIONS (GEE) models 
with a Poisson probability distribution. The Poisson distribution is recommended for use 
when the dependent variable is a count of a rare event; it is a probability distribution in 
that a one-unit increase in a predictor variable corresponds to the exponentiated value of 
that variable's regression coefficient and "is the predicted multiplicative effect of 1-unit 
of change" in the predictor variable (Coxe, West, & Aiken, 2009; p. 125). 
Given the longitudinal nature of the data, we had to account for the dependency 
due to repeated measures. Multilevel modeling statistical techniques are best suited to 
examine both inter- and intra-individual change over time while accounting for this 
dependency (Raudenbush & Bryk, 2002). Moreover, multilevel models can handle 
missing data and permit time between observations to vary (Singer & Willett, 2003). 
While this study was designed to obtain follow-up data from participants every 6 months 
for two years following the baseline personality assessment, there was variability in how 
quickly participants actually completed follow-up assessments. Instead of setting 
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arbitrary dates for all participants, the time variable reflects the actual number of days 
past baseline that the follow-up assessment was completed by a participant
8
, therefore 
providing a more accurate view of how time influences the outcome variables in 
question. Including time in the models also ensured that we could see relationships 
among our variables while holding time constant to avoid any potential confound effects. 
Statistical models were constructed using the following model-building approach. 
First, to evaluate the amount of variation in the outcome variables at level 1, 
unconditional models were run to assess the time-varying effects of health problems (at 
baseline and each follow-up) on change in healthcare utilization, medication use, physical 
health composite score, general health perceptions, depressed mood, subjective well-
being, and social functioning
9
. Separate one-level models were run to test for both the 
linear and quadratic effects of time. Separate two-level models were then run to assess 
the main effects of number of health problems, time, and each PD on the outcome 
variables. Next, separate two-level models were run to assess the interaction effects of 
number of health problems and time, each PD and time, and number of health problems 
and each PD on change in all outcome variables. Also, to determine if personality 
pathology moderated change in physical, psychological, and social functioning over 2.5 
years, a three-way interaction between time, number of health problems, and each PD 
was included in these models. Finally, models were run with all PD features included in 
the models to determine the unique effects of each PD when accounting for the shared 
                                               
8 FU1: mean=194 days (SD=26); FU2: mean=384 (SD=34); FU3: mean=572 days (SD=42); FU4: mean = 
763 (SD=49). 
9 Onset of new health problems were also examined as level 2 variables; see the preliminary analyses 
section for more details. 
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variance among the PDs. Models depicted in the tables include those run with all PDs 
included. 
The covariates included in all models were age, gender, race, and education, 
because of past evidence that these factors have independent associations with health 
outcomes (House, Kessler, & Herzog, 1990; Lahey, 2009). Due to small samples in 
several categories, race of participants was recoded into White/Caucasian and 
Black/African/Other for analyses and were then effect coded (-0.5 and 0.5, respectively, 
for ease of interpretation of coefficients). Gender was also effect coded. For education, 
participants were asked their highest education degree/certificate; the 9 categorical 
response options were then transformed to a continuous variable with a possible range of 
6.5-20 years of education completed. Response options were as follows (years of 
education in parentheses): Elementary or Junior High (6.5); GED (12); H.S. Diploma 
(12); Vocational Tech Degree (14); Associate Degree (14); R.N. Diploma (15); Bachelor 
Degree (16); Master Degree (18); and Doctorate: M.D., Ph.D., J.D., etc. (20). Age and 
education were then centered for all analyses. 
 Throughout model fitting, all multilevel models were compared by deviance 
scores to assess goodness of fit. When chi-square tests showed that adding additional 
terms into the model did not significantly improve fit, the more parsimonious model was 
then used
10
. Covariance parameters were also examined with each new model and only 
models with significant variability at level 1 and level 2 remaining were fitted
11
. Once 
final models were established, non-significant interaction terms were removed from the 
final model (refer to Neslick et al., 2011 for an explanation of reason for this approach).  
                                               
10 Information on all chi-square tests of fit is available upon request. 
11 The social support outcome variable showed limited variability and as a result, no interaction models 
were run. 
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Because of the skewed nature of many of our predictor and outcome variables, it 
was particularly important to evaluate model assumptions (see Raudenbush & Bryk, 
2002; Singer & Willett, 2003). To make sure that the basic assumptions of the models 
were being met, the residuals of all final models were examined to check for error 
normality. The residuals were plotted against fitted values and all residuals of our final 
models approximated a normal distribution. As an additional check, we ran the MLM 
models using restricted maximum likelihood estimates (REML) because the variance 
components estimates are less biased. The standard error estimates were not significantly 
different from those using ML, again supporting that the assumptions of the mixed 
models were adequately met. 
Preliminary analyses 
 Before running all models using a time-varying health status variable, we 
examined the relationships among our variables using dichotomous variables to represent 
the onset of new health problems at each follow-up. Specifically, onset of health problem 
was dummy coded into 7 separate dichotomous variables to account for the presence or 
absence of all possible onset patterns (i.e., onset at only 1 follow-up or new onset at 
multiple follow-ups)
12
. Those dummy codes were then included in all models with a 
separate control variable included for baseline number of illnesses. No significant 
relationships were found between specific onset times, personality pathology, and 
dependent variables in a consistent way. The models also became increasingly 
complicated with >20 interaction terms included in certain models (without accounting 
for models that would also include 10 PD variables), suggesting that looking separately at 
                                               
12 Onset at FU1 only, n=134; onset at FU2 only, n=99; onset at FU3 only, n=71; onset at FU4 only, n=60; 
onset at 2 FUs, n=142; onset at 3 or 4 FUs, n=52. 
 22 
the patterns of change related to these dummy coded variables was not useful in 
answering our research questions. The preliminary analyses did suggest, however, that 
having more events (>2) over the course of the follow-ups was significantly detrimental 
to all functional outcomes, with the exception of social adjustment and emotional well-
being. This trend provided evidence that using a time-varying variable representing the 
number of illnesses for participants from baseline through all follow-ups would provide a 
clearer picture of how health problems impact functioning across a 2.5 year time span. 
CHAPTER 3: RESULTS 
Descriptive Information on Sample 
While the average number of conditions remained relatively low among 
participants over the 2.5 years, some individuals experienced a large number of health 
stressors over the course of the study. The number of health problems participants came 
into the study with at baseline ranged from 0 to 5, with a mean = 0.76 and SD = 0.93. The 
number of new health problems reported at each follow-up were as follows: for FU1, the 
number of new health problems emerging in the 6-month time period ranged from 0 – 3, 
with a mean = 0.20 and SD = (0.47); for FU2, range was 0 – 10, with a mean = 0.23 and 
SD = (0.60)
13
; for FU3, range was 0 – 3, with a mean = 0.21 and SD = 0.50; for FU4, 
range was 0 – 3, with a mean = 0.23 and SD = 0.53. As shown in Table 2, the types of 
medical problems that were experienced in FU1 – FU4 varied widely, with chronic pain 
conditions and rheumatic diseases consistently showing the highest rates across the 
follow-ups.  Approximately 40% of all participants who faced a new medical condition 
also had surgery during that six month time period. 
                                               
13 One participant reported 5 new illnesses, one reported 7 new illnesses, and one reported 10 new illnesses. 
Final models were run with the exclusion of these participants and results did not significant change, so 
they were included in all reported analyses. 
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Effects of PD Features and Illnesses on Physical Functioning  
Parameter estimates of the associations between number of illnesses (across 
baseline and follow-ups), personality pathology, and physical functioning are shown in 
Table 5. On average (when all other predictors are at their mean value), borderline and 
antisocial PD features predicted lower levels of daily physical functioning (β = -15.72, 
p<.001; β = -9.91, p<.05, respectively); that is, independent of time, individuals who 
scored 1 standard deviation above the mean on borderline pathology reported lower 
physical functioning by the degree of 154.1 points, or 1.5 standard deviations below the 
mean in this sample (97.0 fewer points for antisocial PD, or 1 standard deviation below 
the mean). Alternatively, histrionic PD features predicted greater levels of daily physical 
functioning (β = 8.73, p<.01). A negative quadratic interaction between time and 
schizoid PD features was found (β = -0.51, p<.05). As shown in Figure 1, individuals 
with higher levels of schizoid features reported significantly lower levels of physical 
functioning over time compared to individuals with no schizoid features, independent of 
the number of illnesses and other personality pathology present. There was also a positive 
interaction between number of illnesses and time (β = 0.02, p<.05). Individuals with a 
high number of illnesses reported significantly lower levels of physical functioning 
compared with individuals without major illnesses. Interestingly, the level of physical 
functioning slowly decreased over time for individuals with no major illnesses, while 
reported physical functioning actually increased for individuals with higher levels of 
illness over the course of 2.5 years.  
In terms of control variables, older age (β = -1.58, p<.01), female gender  
 24 
(β = -16.28, p<.001), and African American or minority race (β = -30.06, p<.001) were 
predictive of worse reported physical functioning. Higher education level (β = 5.10, 
p<.01) was predictive of better reported physical functioning.
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Table 5 
Final models predicting physical functioning score by number of chronic illnesses (level 1), time (level 1), and personality 
pathology (level 2) 
Baseline   FU4 
Predictor Β Stand. Error t  Predictor β Stand. Error t 
Intercept 508.17 4.77 151.30˟ Intercept 507.46 4.77 106.37˟ 
Age -1.58 0.64 -2.47˟ Age -1.58 0.64 -2.47^ 
Gender -16.28 3.65 -4.45˟ Gender -16.28 3.65 -4.34˟ 
Race -30.06 4.05 -7.40˟ Race -30.06 4.04 -7.40˟ 
Education 5.10 0.54 9.46˟ Education 5.10 0.54 9.71˟ 
Illnesses -27.30 1.54 -15.68˟ Illnesses -15.60 1.54 -10.15˟ 
Baseline time   NS FU4 time   NS 
Baseline time
2
   NS FU4 time
2
   NS 
BPD -15.72 3.20 -4.92˟ BPD -15.72 3.20 -4.92˟ 
HPD 8.73 2.74 3.18˟ HPD 8.73 2.74 3.18˟ 
NPD   NS NPD   NS 
ASPD -9.91 3.88 -2.55^ ASPD -9.91 3.88 -2.55^ 
STPD   NS STPD   NS 
SZPD   NS SZPD -11.31 4.05 -2.70˟ 
PPD   NS PPD   NS 
AVPD   NS AVPD   NS 
DPD   NS DPD   NS 
OCPD   NS OCPD   NS 
B-time*Illness 1.60 0.26 6.19˟ FU4-time*Illness 1.60 0.26 6.19˟ 
B-time
2
*SZPD -0.51 0.17 -3.02˟ FU4-time2*SZPD -0.51 0.17 -3.02˟ 
˟p<.01; ^p<.05 
Note: All significant PD effects were also tested in models without other PD variables and results remained significant.
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Figure 1  
 
 
This figure shows the quadratic interaction between schizoid PD features and time 
predicting physical functioning score. “High levels” reflects 1 SD above the mean. 
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Effects of PD Features and Illnesses on Medication Use  
There were also significant associations between number of illnesses, personality 
pathology, and medication use. Using a Poisson probability distribution, we found a 
significant 3-way positive quadratic interaction between number of illnesses, time, and 
borderline PD features. The predicted number of medication use when all variables are 
held constant at their mean was 1.01 (exp(0.01) = 1.01); see Table 6 for coefficients and 
Figure 2. Individuals with more illnesses were significantly more likely to report greater 
medication use regardless of whether borderline pathology was present; among 
individuals without any reported health problems, borderline features significantly 
predicted greater medication use, although the levels remained lower than for those with 
health problems.  
There were also main effects with other PD features showing that the predicted 
number of medication use when all variables are held constant at their mean was 1.07 for 
narcissistic PD features (exp(0.07) = 1.07); in other words, individuals one standard 
deviation above the mean on narcissistic features reported using 1.07 more medications 
than those low on narcissistic features. Schizotypal PD features predicted less reported 
medication use (exp(-0.11) = 0.90); individuals one standard deviation above the mean on 
schizotypal features reported using 0.90 fewer medications than those low on schizotypal 
features. 
In terms of control variables, male gender (β = -0.11, p<.05), Caucasian race (β = 
-0.18, p<.001), lower education level (β = -0.03, p<.001), and older age (β = 0.03, 
p<.001) were all predictive of higher medication use.
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Table 6 
Final GEE Poisson models predicting medication use by number of chronic illnesses (level 1), time (level 1), and personality 
pathology (level 2) 
FU1  FU4 
Predictor β Stand. Error X2  Predictor β Stand. Error X2 
Intercept 0.76 0.06 155.75˟ Intercept 0.71 0.12 36.69˟ 
Age 0.03 0.01 16.36˟ Age 0.03 0.01 16.36˟ 
Gender -0.11 0.05 5.98^ Gender -0.11 0.05 5.96^ 
Race -0.18 0.05 13.24˟ Race -0.18 0.05 13.24˟ 
Education -0.03 0.01 17.47˟ Education -0.03 0.01 17.47˟ 
Illnesses 0.30 0.03 152.09˟ Illnesses 0.20 0.03 60.32˟ 
FU1 time   NS FU4 time   NS 
FU1 time
2
   NS FU4 time
2
   NS 
BPD   NS BPD   NS 
HPD   NS HPD   NS 
NPD 0.07 0.03 6.91˟ NPD 0.07 0.03 6.91˟ 
ASPD   NS ASPD   NS 
STPD -0.12 0.05 5.05^ STPD -0.12 0.05 5.05^ 
SZPD   NS SZPD   NS 
PPD   NS PPD   NS 
AVPD   NS AVPD   NS 
DPD   NS DPD   NS 
OCPD   NS OCPD   NS 
FU1time
2
*illness*BPD 0.01 0.01 4.09^ FU4time
2
*illness*BPD 0.01 0.01 4.09^ 
˟p<.01; ^p<.05 
Note: All significant PD effects were also tested in models without other PD variables and results remained significant.
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Figure 2  
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This figure shows the quadratic 3-way interaction between borderline PD features, 
number of illnesses, and time predicting medication use from FU1-FU4. “High levels” 
reflects 1 SD above the mean.
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Effects of PD Features and Illnesses on Medical Resource Use  
 
As shown in Table 7, significant associations between number of illnesses, 
personality pathology, and medical resource utilization showed different patterns than 
previous results. There was a significant 3-way negative quadratic interaction between 
number of illnesses, time, and avoidant PD features (β = -0.01, p<.01). Initially, 
individuals with more illnesses and high on avoidant PD features used significantly fewer 
medical resources than individuals with a high number of illnesses but no avoidant 
pathology. However, over time, individuals high on avoidant features and illnesses 
showed greater medical resource utilization than those with a high number of illnesses 
but no avoidant pathology (see Figure 3). We found significant 3-way positive quadratic 
interactions between number of illnesses, time, and dependent PD features (β = 0.02, 
p<.01), as well as obsessive-compulsive PD features (β = 0.01, p<.01). Individuals with 
more illnesses were significantly more likely to use medical resources; while that 
relationship was even greater among individuals high on dependent PD features at FU1, 
the levels of medical resource use became similar over time for all individuals with high 
levels of illnesses. Alternatively, as shown in Figure 4, among individuals with no major 
health problems, those high on dependent features actually showed less medical resource 
use over time compared with those without dependent pathology. The pattern for 
obsessive-compulsive PD was similar to that of dependent PD.  
There were also main effects with other PD features showing that narcissistic and 
antisocial PD features predicted higher reported medical resource utilization (β = 0.11, 
p<.01 and β = 0.17, p<.05, respectively). More specifically, individuals who scored 1 
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standard deviation above the mean on narcissistic and antisocial pathology reported 1.1 
and 1.6 more medical resource use, respectively. 
In terms of control variables, increasing age (β = 0.02, p<.01) and African 
American or other minority race (β = 0.16, p<.001) were predictive of greater use of 
medical resources. 
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Table 7  
Final models predicting medical resource utilization by number of chronic illnesses (level 1), time (level 1), and personality 
pathology (level 2) 
FU1  FU4 
Predictor β Stand. 
Error 
t  Predictor β Stand. 
Error 
t 
Intercept 1.01 0.07 15.07˟ Intercept 1.48 0.21 8.66˟ 
Age 0.02 0.01 2.38^ Age 0.02 0.01 2.38^ 
Gender   NS Gender   NS 
Race 0.16 0.06 2.73˟ Race 0.15 0.06 2.73˟ 
Education   NS Education   NS 
Illnesses 0.72 0.06 13.31˟ Illnesses 0.38 0.06 5.67˟ 
FU1 time   NS FU4 time 0.24 0.10 2.33^ 
FU1 time
2
   NS FU4 time
2
   NS 
BPD   NS BPD   NS 
HPD   NS HPD   NS 
NPD 0.11 0.03 3.32˟ NPD 0.11 0.03 3.36˟ 
ASPD 0.17 0.06 2.78˟ ASPD 0.17 0.06 2.74˟ 
STPD   NS STPD   NS 
SZPD   NS SZPD   NS 
PPD   NS PPD   NS 
AVPD   NS AVPD   NS 
DPD -0.56 0.27 -2.11^ DPD -0.69 0.27 -2.76^ 
OCPD   NS OCPD   NS 
FU1time
2
*illness*AVPD -0.01 0.003 -4.34˟ FU4time2*illness*AVPD -0.01 0.003 -4.34˟ 
FU1time
2
*illness*DPD 0.02 0.007 2.67˟ FU4time2*illness*DPD 0.02 0.007 2.67˟ 
FU1time
2
*illness*OCPD 0.01 0.003 2.22^ FU4time
2
*illness*OCPD 0.01 0.003 2.22^ 
˟p<.01; ^p<.05 
Note: All significant PD effects were also tested in models without other PD variables and results remained significant.
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Figure 3  
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This figure shows the quadratic 3-way interaction between avoidant PD features, number 
of illnesses, and time predicting medical resource utilization from FU1 – FU4. “High 
levels” reflects 1 SD above the mean.
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Figure 4  
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This figure shows the quadratic 3-way interaction between dependent PD features, 
number of illnesses, and time predicting medical resource utilization from FU1 – FU4. 
“High levels” reflects 1 SD above the mean.
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Effects of PD Features and Illnesses on Health Perceptions  
 
When examining the associations between number of illnesses, personality 
pathology, and general health perceptions, borderline PD features predicted worse 
perceptions of health (β = -17.54, p<.001) (see Table 8). Dependent PD features also 
predicted worse perceived health (β = -5.76, p<.05), while histrionic PD predicted better 
perceived health (β = 6.15, p<.01).  
A negative quadratic interaction between number of illnesses and time was also 
found (β = -0.13, p<.05). This pattern was similar to the pattern found with physical 
functioning; that is, individuals with more health problems had significantly worse 
perceptions of health, but those perceptions actually improved over time despite 
increased numbers of health problems. Health perceptions for individuals without major 
health problems remained relatively stable over time. 
In terms of control variables, Caucasian race (β = -18.91, p<.001) and greater 
education level (β = 2.03, p<.01) was predictive of better perceived health. 
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Table 8  
Final models predicting general health perceptions score by number of chronic illnesses (level 1), time (level 1), and personality 
pathology (level 2) 
Baseline  FU4 
Predictor β Stand. 
Error 
t  Predictor β Stand. 
Error 
t 
Intercept 269.91 3.43 108.06˟ Intercept 269.41 3.43 78.65˟ 
Age   NS Age   NS 
Gender   NS Gender   NS 
Race -18.91 3.00 -6.30˟ Race -18.72 3.00 -6.30˟ 
Education 2.03 0.41 5.07˟ Education 2.03 0.41 5.07˟ 
Illnesses -18.22 1.25 -14.50˟ Illnesses -10.16 1.25 -8.58˟ 
Baseline time   NS FU4 time   NS 
Baseline time
2
   NS FU4 time
2
   NS 
BPD -17.54 2.37 -7.39˟ BPD -17.54 2.37 -7.39˟ 
HPD 6.15 2.04 3.01˟ HPD 6.15 2.04 3.01˟ 
NPD   NS NPD   NS 
ASPD   NS ASPD   NS 
STPD   NS STPD   NS 
SZPD   NS SZPD   NS 
PPD   NS PPD   NS 
AVPD   NS AVPD   NS 
DPD -5.76 2.72 -2.12^ DPD -5.76 2.72 -2.12^ 
OCPD   NS OCPD   NS 
B-time
2
*illness -0.13 0.06 -2.05^ FU4-time
2
*illness -0.13 0.06 -2.05^ 
˟p<.01; ^p<.05 
Note: All significant PD effects were also tested in models without other PD variables and results remained significant.
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Effects of PD Features and Illnesses on Depression Score  
As shown in Table 9, there were a number of significant associations between 
number of illnesses, personality pathology, and depression scores. There was a significant 
3-way positive interaction between number of illnesses, time, and histrionic PD features 
(β = 0.08, p<.01). As Figure 5 demonstrates, individuals with more illnesses and high on 
histrionic features started out with significantly lower depressed mood scores at baseline; 
over time, those depression levels reached the same level as for individuals who had 
major health problems but no histrionic pathology. Among individuals who had no major 
health problems, individuals high on histrionic PD features actually reported fewer 
depressive symptoms when compared with those without any histrionic pathology. A 
similar 3-way interaction between number of illnesses, time, and antisocial PD features 
was found (β = 0.07, p<.05). Interestingly, the level of depressed mood for individuals 
with more health problems and high on antisocial PD features exceeded the level for 
those with major health problems but no antisocial pathology over time (see Figure 6). 
There was a significant 3-way negative interaction between number of illnesses, time, 
and schizoid PD features (β = -0.06, p<.05). In contrast to the findings with histrionic 
PD, individuals high on schizoid PD features reported more depressive symptoms than 
those without schizoid pathology, but among those with a high number of health 
problems, that difference eventually disappeared (see Figure 6).  
There were also main effects with other PD features. Borderline features 
significantly predicted higher depression scores (β = 3.34, p<.001); in other words, 
individuals who scored 1 standard deviation above the mean on borderline pathology 
scored almost 33 points higher on the BDI than individuals with no borderline pathology. 
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Avoidant and dependent PD features also significantly predicted higher depression scores 
(β = 0.71, p<.001; and β = 0.90, p<.001, respectively), although these associations were 
smaller. 
In terms of control variables, increasing age (β = -0.12, p<.01) and higher 
education level (β = -0.18, p<.01) were predictive of lower depressed mood scores, while 
African American or minority race (β = 0.78, p<.01) was predictive of higher depressed 
mood scores.
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Table 9 
Final models predicting depression score by number of chronic illnesses (level 1), time (level 1), and personality pathology (level 2) 
Baseline  FU4 
Predictor β Stand. 
Error 
t  Predictor β Stand. 
Error 
t 
Intercept 2.79 0.25 11.16˟ Intercept 2.46 0.25 6.09˟ 
Age -0.12 0.04 -2.73˟ Age -0.12 0.04 -2.73˟ 
Gender   NS Gender   NS 
Race 0.78 0.27 2.88˟ Race 0.78 0.27 2.88˟ 
Education -0.18 0.04 -5.03˟ Education -0.18 0.04 -5.03˟ 
Illnesses 0.78 0.18 4.29˟ Illnesses 0.56 0.18 3.03˟ 
Baseline time   NS FU4 time   NS 
Baseline time
2
   NS FU4 time
2
   NS 
BPD 3.34 0.21 15.48˟ BPD 3.34 0.21 15.87˟ 
HPD   NS HPD   NS 
NPD   NS NPD   NS 
ASPD   NS ASPD   NS 
STPD   NS STPD   NS 
SZPD   NS SZPD 0.80  3.02˟ 
PPD   NS PPD   NS 
AVPD 0.71 0.12 5.80˟ AVPD 0.71 0.12 5.80˟ 
DPD 0.90 0.24 3.69˟ DPD 0.90 0.24 3.69˟ 
OCPD   NS OCPD   NS 
B-time*illness*HPD 0.08 0.03 2.75˟ FU4-time*illness*HPD 0.08 0.03 2.75˟ 
B-time*illness*ASPD 0.07 0.03 2.07^ FU4-time*illness*ASPD 0.07 0.03 2.07^ 
B-time*illness*SZPD -0.06 0.02 -2.40^ FU4-time*illness*SZPD -0.06 0.02 -2.41^ 
˟p<.01; ^p<.05 
Note: All significant PD effects were also tested in models without other PD variables and results remained significant.
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Figure 5  
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This figure shows the 3-way interaction between histrionic PD features, number of 
illnesses, and time predicting depressed mood score. “High levels” reflects 1 SD above 
the mean.
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Figure 6  
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Figure 7  
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Effects of PD Features and Illnesses on Emotional Well-being  
Main effect patterns of personality in predicting emotional well-being were 
similar to those found with depressed mood scores. Borderline, avoidant, and dependent 
PD features all significantly predicted lower reported emotional well-being (β = -32.37, 
p<.001; β = -7.68, p<.001; and β = -9.34, p<.001, respectively). Histrionic PD features 
were predictive of higher reported emotional well-being (β = 6.52, p<.01). There was 
also a significant main effect with number of illnesses, showing that the more illnesses 
individuals’ experienced, the worse their reported emotional well-being (β = -4.44, 
p<.001). Additionally, a quadratic effect of time on emotional well-being was found (β = 
0.57, p<.001). Age was the only significant control variable in relation to emotional well-
being (β = 1.75, p<.001). Because no interactions were found with emotional well-being, 
the values are not included in a table. 
Effects of PD Features and Illnesses on Social Adjustment Levels  
There were also a number of significant PD main effects in relation to social 
adjustment levels. More specifically, we found that borderline, schizoid, avoidant, and 
dependent PD features all significantly predicted lower reported social functioning         
(β = -1.10, p<.001; β = -0.77, p<.001; β = -0.49, p<.001; and β = -0.29, p<.001, 
respectively). As might be expected, histrionic PD features were predictive of higher 
reported social functioning (β = 0.44, p<.01). Greater number of illnesses was also 
associated with lower reported social functioning (β = -0.12, p<.05). There was a 
quadratic main effect with time (β = 0.02, p<.01). 
In terms of control variables, increasing age (β = 0.08, p<.01), female gender (β = 
0.44, p<.01), and higher education level (β = 0.05, p<.01) were predictive of greater 
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reported social functioning, while African American or minority race (β = -0.42, p<.01) 
was predictive of lower reported social functioning. Because no interactions were found 
with social functioning, the values are not included in a table. 
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Table 10 
Summary of findings  
 Physical 
Functioning 
Medication 
Use 
Medical Resource 
Utilization 
Health 
Perceptions 
Depressed Mood Emotional 
Well-being 
Social 
Adjustment 
Physical 
Illnesses 
Lower Higher Higher Lower Higher Lower Lower 
PD features:        
Borderline Lower Higher use 
among 
people w/out 
illnesses 
 Lower Higher Lower Lower 
Antisocial Lower  Higher  Initially lower, but 
increased over time 
for people w/ 
illnesses 
  
Histrionic Higher   Higher Increased over time 
for people w/ 
illnesses; lower for 
people w/out 
illnesses 
Higher Higher 
Schizoid Lower over 
time 
   Higher for people 
w/out illnesses 
 Lower 
Narcissistic  Higher Higher     
Schizotypal  Lower      
Avoidant   Lower initially; 
higher over time for 
people w/ illnesses 
 Higher Lower Lower 
Dependent   Higher initially; 
lower for people 
w/out illnesses 
Lower Higher Lower Lower 
Obsessive-
compulsive 
  Slightly higher 
initially for people w/ 
illnesses, but 
decreased w/ time  
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Covariates:        
Age Lower Higher Higher  Lower Higher Higher 
Female Gender Lower Lower     Higher 
Minority Race Lower Lower Higher Lower Higher  Lower 
Education Higher Lower  Higher Lower  Higher 
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CHAPTER 4: DISCUSSION 
This is the first longitudinal study to assess the relationship between personality 
pathology, physical health-related conditions, and functioning in later adulthood. 
Consistent with previous research on the detrimental effects of PDs (Bender et al., 2001; 
Pagano et al., 2004; Piertzak, Wagner, & Petry, 2007; Zanarini et al., 2005), we found 
that some types of personality pathology had a significant negative impact on physical, 
psychological, and social functioning over the 2.5 years examined. In particular, 
borderline, avoidant, and dependent PD features emerged as significant predictors of 
worse functioning across all three domains. Much of the research done with younger 
adults has focused on worse functioning among individuals with borderline PD (e.g., El-
Gabalawy et al., 2010; Frankenburg & Zanarini, 2006a, 2006b). In our older adult 
sample, the results were similar. Above and beyond the effects of demographic variables 
and health status, borderline pathology predicted worse physical functioning, lower 
perceived health, increased depressive symptoms, lower reported emotional well-being, 
and lower social functioning. We did not find a significant association between 
borderline pathology and medical resource utilization when other PD features were 
included in the model. The patterns were similar in the psychological and social domains 
for avoidant and dependent PD features; individuals with higher levels of avoidant and 
dependent pathology showed an increased likelihood of depressive symptoms, lower 
reported emotional well-being, and lower social functioning.  
What is it about borderline pathology that would cause worse functioning across 
these three domains in this older adult sample? Many of the problematic symptoms 
characteristic of borderline pathology have been shown to decrease over time; for 
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example, self-injurious or impulsive behaviors are less likely to be present as individuals 
age (Blum et al., 2008). This is generally supported by the very low prevalence of 
borderline PD as a categorical disorder in our sample. Despite this, recent evidence on the 
stability (or instability) of borderline PD suggests that while many symptoms seem to 
remit over time, the long term negative consequences of the disorder are still very strong 
(Blum et al., 2008; Gunderson et al., 2011). The strong associations between borderline 
features and negative outcomes found in this study further demonstrate that functional 
problems do continue into older adulthood. 
It is possible that by later adulthood, we see both the long-term consequences of 
past behavioral and affective patterns as well as the consequences of current negative 
patterns. For example, impulsivity may not directly cause as many problems at this 
developmental stage, but the repercussions of past health choices may continue to affect 
the individual. Additionally, poor social functioning (as a result of unstable interpersonal 
relationships and unhealthy behavioral patterns throughout life) may be particularly 
detrimental for health and functional outcomes in older adulthood because of the role 
social support plays in coping with stress and promoting well-being (Cohen, 1988; 
Uchino, 2009). Finally, affective instability, a feature that is often the most consistent 
over time and is suggested to underlie many of the other borderline symptoms, is 
associated with worse psychosocial functioning and may continue to play a strong role in 
older age (Tragesser, Solhan, Schwartz-Metter, & Trull, 2007; Zanarini, Frankenburg, 
Hennen, & Silk, 2003). Affective instability makes it difficult for individuals to manage 
their emotions, cope with negative feelings, and even self-soothe. These individuals, 
when faced with a negative event such as a health problem, may become overwhelmed 
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by strong negative emotions and without an adequate way to reduce the emotion may 
shut down or act out in ways that then further affect their ability to function.   
The patterns of results for avoidant and dependent PD features may reflect the 
social impairment and low positive affect associated with these disorders. Avoidant PD is 
characterized by avoidance of intimate and interpersonal relationships because of fear of 
rejection and judgment, while dependent PD is characterized by overly needy behavior in 
relation to others and fears of being alone. Despite their differences, both disorders reflect 
a strong desire for relationships and an inability to foster such relationships adequately. 
Recent research into the effect of loneliness on older adults suggests the vital role that 
social interactions play in keeping us healthy and happy (Hawkley & Cacioppo, 2010). 
Furthermore, individuals with these personality pathologies are unlikely to have certain 
positive personality features (e.g., positive affect, optimism) that can benefit health 
outcomes, the ability to deal with stress, and increase social support (Cohen & Pressman, 
2006). Since much of the research on PDs up to this point has been done with younger 
adults, it may be that risk associated with these PD features has been underestimated, and 
that such features emerge more as risk factors for negative health and functional 
outcomes among older adults.  
Other PD features were related to the functional outcomes in our sample as well, 
although the findings varied, suggesting that PD features do in fact affect functioning in 
different ways. For example, antisocial PD features were predictive of worse reported 
physical functioning and more medical resource utilization, while narcissistic PD features 
were predictive of medication use and medical resource utilization. Schizoid PD features 
were related to worse physical functioning and worse social functioning. In contrast, 
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histrionic PD demonstrated a positive association with physical functioning and 
perceived health, as well as with greater social functioning scores, which might be 
expected considering the criteria for histrionic PD include items related to desire for 
social attention and exaggerated perception of relationship closeness.  The association 
with schizoid PD features and lower social functioning also makes sense because of the 
social isolation characteristic of schizoid PD. Because these individuals typically do not 
desire interpersonal contact and relationships, we would expect them to report less social 
interaction on a regular basis. This may also carry over into physical functioning because 
there are fewer positive motivators to get out and engage in pleasurable activities; if 
someone is in pain and spends the majority of their time alone or working, it may be 
easier to focus on what they cannot do in relation to physical activities, as opposed to 
what they can do. Again, good social adjustment has been shown to be increasingly 
important in positive functioning and well-being as individuals’ age (Hawkley & 
Cacioppo, 2010; Uchino, 2009). The positive association of histrionic PD features with 
physical functioning and perceived health is unexpected and more research should be 
done before any clear conclusions can be made. 
Although the research on most PDs in relation to physical health is limited, there 
is already some evidence that antisocial PD is related to negative health outcomes, 
perhaps as a result of past impulsive acts or lifetime substance use (Frankenburg & 
Zanarini, 2006b). The link found in our sample between antisocial features, physical 
functioning, and medical resource utilization could also be reflective of the longer term 
effects of antisocial behavior, although the scope of this study does not allow for any 
clear determinations about risk pathways. The role of narcissistic features in physical 
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health and functioning is less clear. One possibility for understanding long-term health 
consequences of narcissistic PD may lie in recent research on narcissistic vulnerability 
(see Pincus & Lukowitsky, 2010 for a review of this concept) and the dysfunctional 
characteristics associated with it (i.e., poor self-image and self-criticism, affective 
instability, interpersonal problems, and suicidality). Although much more research needs 
to be done in this area, this “hidden” part of narcissistic PD includes features that are 
already linked to negative health consequences on their own, such as high negative affect 
and anger (Dembroski, & Costa, 1987; Lahey, 2009; Smith & MacKenzie, 2006).  
Also in support of past research (Fortin et al., 2006), the number of health 
problems individuals experienced had a significant effect on the three areas of 
functioning over time. Increasing number of health problems was predictive of worse 
physical functioning, greater medication use, greater medical resource utilization, worse 
perceived health, increased number of depressive symptoms, lower emotional well-being, 
and worse social functioning. Interestingly, certain outcome variables, including physical 
functioning and perceived health scores, actually improved over time despite the 
continued stress of chronic illnesses (and added stress of new health problems). There are 
a number of reasons why this may have happened. One possibility is that, in general, 
individuals with health problems are able to adjust to the difficulties associated with their 
conditions over time. Because the pain or role limitations that may come with a chronic 
condition like arthritis do not go away, the individual is likely to adjust their life, and 
even their attitude toward the health problem, in a way that actually makes them feel 
more physically functional or healthier. Furthermore, in working with a medical doctor, 
the individual is likely to take medications or implement behavioral strategies that help 
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control symptoms over time and may make the individual feel better even if the condition 
is still present. 
In examining the combined effects of health problems and personality pathology 
over time, we were also able to determine if personality pathology moderates those 
negative effects found with health-related stress on functional outcomes. Our results 
showed that certain pathological personality patterns did alter the effects of health 
problems on medication use, medical resource utilization, and depressed mood. In 
support of our hypothesis, we found that borderline pathology did have an effect on 
medication use in this sample. Although individuals with health problems and borderline 
pathology used a similar number of medications to those with health problems but no 
borderline pathology, individuals with borderline pathology and no health problems 
showed significantly greater medication use than those individuals without health 
problems or borderline pathology. The difference in medication use still remained 
relatively small, and so the implications of this finding may be limited. It is possible that 
the increased medication use is actually related to medication for psychological 
symptoms, as opposed to physical symptoms, and it would make sense that individuals 
with borderline pathology are more likely to be taking some kind of antidepressant or 
antianxiety medication. However, it is unclear why that difference would not also show 
up in the group with physical health problems. As we continue to follow these individuals 
into older adulthood, it may become easier to determine the nature of this relationship 
and how it should be understood in the context of health and general functioning. 
The interaction effect between avoidant pathology and health problems in 
predicting medical resource utilization was quite different. Individuals with health 
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problems and higher levels of avoidant pathology reported fewer medical visits at 
baseline; however, over time, those individuals showed significantly greater medical 
resource utilization than individuals with health problems but no avoidant pathology. 
This suggests that while avoidant individuals may at first not seek out treatment even 
when sick, as the illness load increases, their behavior actually switches and they then 
overcompensate, going to the doctor more than individuals with health problems but no 
avoidant pathology. Alternatively, patterns with dependent and obsessive-compulsive PD 
features showed that initially individuals with health problems and high on dependent and 
obsessive-compulsive pathology used more medical resources than individuals with 
health problems but no pathology. Over time, those differences reduced and by follow-up 
4, these individuals were reporting slightly less medical resource utilization than 
individuals with health problems and no pathology, although the levels remained higher 
than for those individuals without any health problems.  
Our hypothesis that borderline pathology would moderate medical resource 
utilization was not supported. This was surprising given the previous evidence of over-
utilization of medical resources among individuals with borderline pathology (e.g., 
Bender et al., 2001). It is possible that we did not find this effect because our range of 
borderline pathology is quite limited. It is also possible that, similar to what was found 
with many other outcomes measured in this study, borderline pathology has a negative 
effect on medical resource use whether or not health problems are present. When only 
borderline pathology was included in the model, it was predictive of greater medical 
resource utilization. However, once all PDs were entered in together, that relationship 
was no longer significant suggesting that there may be something more general across the 
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PD features that helps predict overutilization in our sample, rather than something unique 
to borderline features above and beyond what is shared among the PDs. 
With depressed mood and emotional well-being, our hypotheses regarding 
borderline pathology were also not supported. Borderline pathology did not moderate the 
impact of health stressors on these outcomes. Instead, the negative impact of borderline 
pathology remained relatively stable over time; individuals with borderline features 
reported significantly higher depressed mood scores and lower emotional well-being 
scores, independent of the number of health problems experienced over the 2.5 years. 
Even though borderline pathology did not interact with health problems, we see the very 
serious effects of borderline features on mood and must keep that in mind because of how 
significantly depression can affect health and functioning as well.  
Our results with depressed mood scores and other personality pathology still 
provide a very clear demonstration of how the combination of health stressors and 
personality pathology can interact to produce negative results. For individuals high on 
histrionic or antisocial pathology, a higher number of health problems was associated 
with significantly higher depressed mood scores over time, while depressed mood scores 
were either similar or even lower when health problems were not present. These 
interaction effects suggest that these individuals may have a much more difficult time 
coping with the stress of their health problems and are more likely to endorse depressive 
symptoms as a result. Interestingly, individuals with schizoid pathology reported more 
depressive symptoms than those without schizoid pathology; however, when individuals 
had a higher number of health problems, those differences in mood scores decreased over 
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time and by 2.5 years, depressed mood was similar among those with or without schizoid 
pathology. 
These varied findings support our need for continued research on the role of 
personality pathology in physical health and functioning. Clearly it is valuable to evaluate 
the whole spectrum of PD features. However, our measurement of health problems in the 
present study focused on a wide range of health problems and it is possible that by 
narrowing the scope to a single physical condition or more restricted group of conditions, 
more cohesive patterns would emerge. It makes sense that some health problems, such as 
chronic pain or diabetes, may be more likely to be influenced by PD features than other 
health problems, such as stroke. In the future, we hope to tease apart such relationships 
with the goal of finding specific risk factors that can then be targeted in medical settings. 
We also found a number of important main effects with our demographic 
covariates across the three functional domains. As might be expected, older age was 
predictive of worse reported physical functioning, greater medication use, and greater 
medical resource utilization. Interestingly, older age was also predictive of higher 
reported emotional well-being, lower depressed mood scores, and greater reported social 
functioning, suggesting that although health and physical functioning may continue to 
decline as individuals’ age, mood and well-being actually improves. Recent research has 
begun to focus on this emotional side of aging and provides one possible answer for why 
we find this result. Carstensen and colleagues (2005) have shown that a positivity effect 
occurs as individuals age; while younger adults tend to process negative material more 
readily, a shift occurs as individuals age and positive material is increasingly favored. 
Socioemotional selectivity theory posits that this shift in focus to positive emotional 
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stimuli is a result of the growing awareness by older adults that time is limited, and 
attention becomes directed to more emotionally meaningful aspects of life and thus 
promotes emotional well-being.  
Our findings regarding education and race fit in the broader context of research on 
health disparities and socioecomonic status (Cutler & Lleres-Muney, 2010; Kendzor et 
al., 2009; Lodi-Smith et al., 2010; Mezuk et al., 2010). Higher education level was 
predictive of better reported physical functioning, lower medication use, lower depressed 
mood, and higher social functioning. African American or minority race was predictive 
of worse reported physical functioning, greater medical resource utilization, lower 
perceived health, higher depressed mood, and lower social functioning. There is 
extensive evidence to show that African Americans and other minorities experience 
profound health disparities (e.g., Mensah et al., 2005; Miller et al., 2004), so it is not 
surprising to see worse functioning in the physical health domain within our sample. 
However, the relations with higher depressed mood and lower social functioning is in 
contrast to previous findings showing that African American individuals tend to be more 
resilient to depression than Caucasians and also have greater community connections and 
social support (Keyes, 2009; Mezuk et al., 2010). BDI score certainly does not reflect a 
diagnosis of major depression, and that may be one reason for the disparity. More 
research is needed before a clear determination of these associations can be made. 
This unique sample allows us to show that the detrimental impact of personality 
pathology continues across the lifespan. Although some PD features may decrease as 
individuals enter later adulthood, the negative effects of pathology even at low levels can 
still be seen from our results. The presence of borderline PD features was predictive of 
 57 
worse functioning across all three outcome domains, regardless of health status. For other 
PD features, like antisocial or avoidant PD, negative effects on outcomes such as mood or 
medical resource utilization did not appear unless there were also significant health 
problems present. This suggests that as individuals enter a time of life when health 
problems are increasingly common, new difficulties with functioning may appear when 
individuals with personality pathology are faced with health-related stressors. Our 
research group is looking forward to continuing to research this and use additional 
follow-up data to determine how significant these effects really are on functioning and 
how long they persist (or possibly strengthen) over time.  
Limitations 
A number of limitations should be kept in mind when interpreting the results of 
these analyses.  The first is the use of self-report to measure chronic physical health 
conditions across all 5 time points.  The scope of the present study did not allow for 
thorough medical testing (e.g., the use of multidetector scanners to measure coronary 
artery calcification) or the cooperation of participants’ medical doctors to provide 
corroboration.  Although it would have been ideal to have had access to medical records 
to check participants’ reports of physical illnesses, researchers have found little 
discrepancy between self-reports of physical illnesses and documented medical histories 
(Goodwin & Engstrom, 2002).  Within the present study, we used the phrase “Have you 
ever been diagnosed by a doctor as having…” when asking about physical health 
problems in an effort to reduce participants’ self-reported ailments and get them to think 
about whether they actually went to a doctor to receive treatment for a given condition. In 
addition, we created inclusion criteria for health problems reported at follow-ups to help 
 58 
ensure the significance of the problems reported. These were not perfect measures of 
chronic physical health problems by any means, but the use of self-report allowed us to 
ask important questions about health within the larger SPAN project.  
We also used self-report of medical resource utilization and medication use. 
While this is the standard method for measuring these variables, issues of reliability must 
be kept in mind (see Bhandari & Wagner, 2006 for more details regarding this issue). 
One of the factors that can greatly affect accuracy in reporting is the length of time 
individuals are asked to recall. We used a 6-month time frame for the present study and 
this shorter time frame likely helped with general accuracy, although that cannot be 
determined based on measurement methods. Additionally, for medication use, we asked 
participants to list out the names of medications they were taking and the reasons for use 
in an effort to reduce the likelihood that participants would simply estimate the number of 
drugs they were taking during the follow-ups. 
Because we studied adults living in the community rather than focusing 
exclusively on clinical patients, our sample does not include a large number of 
individuals with extreme levels of personality pathology.  However, roughly 10% of our 
sample met DSM-IV-TR criteria for at least one PD (using the SIDP), as expected based 
on previous epidemiological studies (9.1%) (Lenzenweger et al., 2007).  Almost half of 
the people in our sample (>40%) have received some kind of mental health treatment, 
demonstrating that individuals with varying levels of psychopathology were represented 
in this data set (Lawton & Oltmanns, unpublished manuscript). Furthermore, we 
measured PDs on a continuous scale rather following the categorical approach to 
diagnosis included in DSM-IV-TR.  Measuring PDs according to the presence of 
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symptoms allowed us to capture the full range of variability in personality pathology 
evident in this sample. 
Finally, this research was conducted on a very specific group of individuals 
(adults aged 55-64), and the generalizability of these findings to other age groups should 
be considered carefully.  The focus of this study, however, was on how PD symptoms 
relate to general functioning in the face of health-related stressors. The range of health 
status in our sample actually allowed for greater variability than would be found in 
younger participants.  Older adults may represent a population in which the impact of 
personality pathology on physical health is stronger than might be found with younger 
participants, and therefore this may be an even more important population in which to 
study such associations.  
Conclusions and Future Directions 
The results of the present study further support the growing evidence that 
borderline pathology leads to worse physical, psychological, and social functioning, 
showing that even at subthreshold levels of pathology, individuals with borderline 
features show significantly worse outcomes into later adulthood. Other PD features 
should not be ignored, however. There is still a great deal to learn about how the risk 
associated with personality pathology may shift as individuals age. PD features do 
change as individuals age, and so we should expect the consequences of those features to 
change as well. Emerging evidence of the importance of social support and functioning in 
later adulthood (and in the face of health problems) means that the social and 
interpersonal dysfunction found in all the PDs may come to affect individuals in new 
ways. Furthermore, certain PD features may become more problematic in later adulthood 
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and so research should be done to identify what particular features drive these negative 
effects. 
Since research on PDs in later adulthood is only in the beginning stages, there is 
so much more to understand. In addition to studying pathology across the lifespan, 
researchers should also commit to studying pathology in different kinds of settings. Much 
of the longitudinal research on PDs until now has been done on small clinical samples. 
While understanding the detrimental effects of severe psychopathology is important, it 
may be particularly beneficial to explore these effects in community samples when 
dealing with an older age range. This type of sample would allow for the variability in 
health problems and personality pathology that a medical doctor may see in a medical 
clinic, and thus allows us to see what kinds of negative outcomes to expect.   
There is mounting evidence of the health burden and healthcare costs associated 
with personality pathology. Therefore, efforts to identify and treat PDs should be at the 
forefront of mental health research and treatment. As the healthcare field shifts to a focus 
on preventative medicine, early intervention and the treatment of psychopathology should 
be included in that plan. Personality pathology interferes with many aspects of health, 
from medical adherence to health-related behaviors to general functioning; but, evidence 
shows that when PDs are treated, there are significant reductions in healthcare utilization 
for up to three years following completion of treatment (Davies & Campling, 2003). It is 
impossible to consider mental and physical health separately, and as this study has 
shown, the presence of health problems can make functioning particularly difficult for 
individuals with personality pathology. Therefore, we must begin to think about ways to 
treat both together in an effort to promote better health and functioning for any age group. 
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APPENDIX A 
 
Conditions Included in Each Illness Category: 
 Heart disease 
- Heart failure  
- Cardiac arrest 
- Artery blockage 
- Diastolic dysfunction 
- Bypass surgery 
- Aortic aneurism 
- Myocardial infarction 
- Mitral valve prolapse  
- Cardiac catherization 
- Re-entry tachycardia 
- Arterial fibrillation 
- Blood clots 
 Cancer 
- Melanoma 
- Breast  
- Prostate  
- Colon 
- Cervical 
- Thyroid 
- Chronic myeloid leukemia 
- Endometrial adenocarcinoma 
 Stroke 
- Transient Ischemic Attack 
 Rheumatic Diseases 
- Rheumatoid mass 
- Arthritis Psoriatica 
- Lupus 
- Sjongren’s syndrome 
- Scleroderma arthritis 
 Diabetes 
 Hypertension 
 High Cholesterol 
 Chronic lung problems 
- Chronic obstructive pulmonary disease 
- Asthma 
- Bronchitis 
- Emphysema 
- Pulmonary edema 
 Gastrointestinal disorders (Digestive diseases) 
- Colitis 
- Small intestinal bacterial overgrowth 
- Post-cholecystectomy syndrome 
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- Gastro-esophigal reflex disease 
- Diverticulitis 
- Rectal malformation 
- High liver enzymes 
- Inflamed small intestine 
- Barrett’s esophagus 
- Blocked colon 
- Esophageal ulceration 
- Rectal hernia 
- Pharyngeal diverticulum 
- Gastroparesis 
- Liver disease 
 Genitourinary problems 
- Kidney failure 
- Bladder stress 
- Kidney stones 
- Overactive bladder 
- Sacrospinous colopexy 
- Enterocele repair  
- Rectocele repair 
- Kidney disease 
- Incontinence 
- Anal fissure 
- Prolapsed uterus 
- Enlarged prostate 
- Prostate surgery 
- Hemmroids 
- Fibroids 
 Osteoporosis 
- Bone deficiency 
- Osteopenia 
- Bone loss 
 Chronic Pain 
- Knee pain 
- Foot pain 
- Ankle pain 
- Hip pain 
- Back pain 
- Carpal tunnel syndrome 
- Shoulder impingement syndrome 
- Degenerative lumbar disc disease 
- Foot neuroma 
- Injured fibular nerve 
- Frozen shoulder 
- Sacroiliac  
- Cervical myelopathy 
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- Trigeminal neuralgia 
- Cervicalgia 
- Spinal stenosis 
- Lumbar spinal deterioration 
- Scoliosis 
- Degenerative joint disease 
- Spurs on pelvis 
- Cervical dystonia 
 Brain tumor/aneurism 
 Hernia 
- Spondylothesis 
- Non-union of cervical fusion 
 Torn muscle/broken bone 
- Knee injury 
- Foot injury 
- ACL injury  
- Torn medial meniscus  
- Collapsed bone in foot 
- Broken back 
- Costochondritis 
- Broken rib 
- Torn cartilage  
- Broken sternum 
 Thyroid 
- Hypothyroidism 
- Hyperthyroidism 
 Eye problems 
- Glaucoma 
- Retinal vein occlusion 
- Bilateral iridectomy 
- Iritis  
- Detached retina 
- Anterior basement membrane corneal dystrophy 
- blepharoplasty     
- Botched eye surgery                                                                                                         
 Dental problems 
- Root canal  
 Ear problems 
- Hearing loss 
- Meniere’s 
 Gastroesophageal reflux disease 
 Joint replacement 
- Knee replacement 
- Shoulder replacement 
- Toe replacement 
 Other 
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- Sleep apnea 
- Bed sore 
- Parkinson’s disease 
- Tendonitis  
- Hypercapnia 
- Vocal cord polyps  
- Traumatic brain injury 
- Auto-immune condition 
- Essential tremors in voice 
- Loss of smell 
- Hypokalemia 
- Amputation 
- Leg stents 
- Chronic autoimmune urticaria 
- Epilepsy 
 
Conditions or symptoms not included: 
 Infections 
- Appendicitis / Appendectomy 
- Cellulitis 
- Infection in left breast 
- Whooping cough 
- Pneumonia 
- Urinary tract infection 
- Influenza 
- Colon infection 
- Shingles (Herpes Zoster) 
- E.Coli 
- Bladder infection 
- Human Papiloma Virus (HPV) 
- Sinus infection 
- Ear infection 
- Salivary gland stone (sialolithiasis) 
 Symptoms or surgeries not included 
- Cyst removed 
- Non-cancerous mole removed 
- Mass on hand 
- Swelling of left foot 
- Left shoulder sore 
- Ringing in ears 
- Atypical cells 
- Weakness in leg 
- Low vitamin D 
- Low testosterone 
- Swelling in ankles 
- Colonoscopy 
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- Biopsy 
- Eyebrow lift 
 
Descriptive details of reported health conditions not included in analyses: 
 FU1 FU2 FU3 FU4 
N (%) N (%) N (%) N (%) 
Health Conditions 
Not Included 
54 (3.7) 71 (5.4) 40 (4.0) 37 (4.4) 
Reason:     
Did not meet 
inclusion criteria 
20 (1.4) 22 (1.7) 10 (1.0) 5 (0.6) 
Missing a 
description 
14 (1.0) 17 (1.3) 11 (1.1) 15 (1.8) 
Only described a 
symptom  
2 (0.1) 10 (0.8) 3 (0.3) 5 (0.6) 
Infection 
 
11 (0.8) 12 (0.9) 6 (0.6) 8 (0.9) 
Psychopathology 
 
2 (0.1) 3 (0.2) 2 (0.2) 1 (0.1) 
Cosmetic Surgery 
 
1 (0.1) 1 (0.1) 3 (0.3) 1 (0.1) 
Routine 
Testing/Surgery 
4 (0.3) 6 (0.5) 5 (0.5) 2 (0.1) 
 
 
 
